IP Library Patent Application 12268381
Patent Application
App. No. 12/268,381

TISSUE VISUALIZATION AND ABLATION SYSTEMS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/268,381
Abstract

Visualization and ablation system variations are described which utilize various tissue ablation arrangements. Such assemblies are configured to facilitate the application of energy delivery, such as RF ablation, to an underlying target tissue for treatment in a controlled manner while directly visualizing the tissue during the bipolar ablation process.

Claims (31)

1 . A tissue treatment system, comprising:

a reconfigurable hood which is capable of intravascular delivery in a low profile delivery configuration and expansion to a deployed configuration which defines an open area;

a fluid lumen in communication with the open area of the structure such that introduction of a conductive fluid through the lumen purges the open area of blood when the structure is further bounded by a tissue surface; and

an electrode supported by at least one support member, wherein the electrode is positionable adjacent to the open area in the deployed configuration and distally of the hood in the delivery configuration.

2 . The system of claim 1 further comprising an imaging element within or along the hood such that the open area is contained within a visual field of the imaging element.

3 . The system of claim 1 wherein the fluid lumen is positionable within or along the instrument.

4 . The system of claim 1 wherein the electrode is positionable distal to an aperture defined in a membrane spanning the hood.

5 . The system of claim 4 wherein the electrode defines a circular configuration approximating a size of the aperture.

6 . The system of claim 4 wherein the hood further comprises a porous membrane positioned over the aperture, wherein the porous membrane further defines a plurality of openings.

7 . The system of claim 4 wherein the membrane further comprises one or more ridges or barriers extending along the membrane.

8 . The system of claim 1 wherein the electrode is supported by a first support member and a second support member, each member defining a curve or bend approximating a shape of the hood.

9 . The system of claim 1 wherein the electrode is configured for provide ablation energy.

10 . The system of claim 1 wherein the electrode is configured to sense or detect electrophysiological activity from the tissue surface.

11 . A method of deploying a tissue treatment system, comprising:

intravascularly advancing an outer sheath to a tissue region of interest;

urging an electrode supported by at least one support member from the outer sheath;

urging a hood in a low profile delivery configuration from the outer sheath such that the hood is reconfigured into a deployed configuration and defines an open area, and wherein the electrode is positioned adjacent to the open area in the deployed configuration.

12 . The method of claim 11 wherein intravascularly advancing comprises passing through an inferior or superior region of an atrial transseptal wall.

13 . The method of claim 11 further comprising visualizing the tissue region bounded by the open area with an imager positioned within or along the hood.

14 . The method of claim 11 further comprising purging blood from within the hood via a transparent fluid introduced through a fluid lumen in communication with the open area.

15 . The method of claim 14 further comprising reducing a flow of the transparent fluid from the open area via a porous membrane defining a plurality of openings.

16 . The method of claim 14 further comprising distributing the flow of transparent fluid between a membrane spanning the open area and the tissue region.

17 . The method of claim 11 wherein the electrode is supported by a first support member and a second support member, each member defining a curve or bend approximating a shape of the hood.

18 . The method of claim 11 further comprising ablating the tissue region of interest via the electrode in contact with the tissue region.

19 . The method of claim 11 further comprising sensing or detecting electrophysiological activity from the tissue region via the electrode.

20 . The method of claim 11 further comprising retracting the hood proximally into the outer sheath separately from the electrode.

21 . A tissue treatment system, comprising:

an hood having a low profile intravascular delivery configuration and a deployed configuration, the hood in the deployed configuration defining an expanded interior volume having a distal open area;

an elongate body having a fluid lumen in communication with the volume such that introduction of a conductive fluid distally through the lumen purges the open area of blood when the deployed hood is disposed within a blood-filled site within a patient and the open area is adjacent a tissue surface;

an electrode; and

at least one support member extending distally from the elongate body so as to position the electrode adjacent to the open area in the deployed configuration and distally of the hood in the delivery configuration.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2013
From: TRIPLEPOINT CAPITAL LLC
To: VOYAGE MEDICAL, INC.
Reel/Frame 031029/0949 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2013
From: VOYAGE MEDICAL, INC.
To: INTUITIVE SURGICAL OPERATIONS, INC.
Reel/Frame 031030/0061 →
SECURITY AGREEMENT Recorded Sep 24, 2012
From: VOYAGE MEDICAL, INC.
To: TRIPLEPOINT CAPITAL LLC
Reel/Frame 029011/0077 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2009
From: SAADAT, VAHID; MALCHANO, ZACHARY J.; MILLER, DAVID; PEH, RUEY-FENG
To: VOYAGE MEDICAL, INC.
Reel/Frame 022157/0635 →